Skip to content
Clinical Trials – home
Therapeutic area

Vascular disorders – page 4

  • 837 clinical trials
  • 354 recruiting
  • 378 conditions
  • 28 countries

Conditions in this area

378 conditions with trials, the busiest first

Clinical trials in Vascular disorders

837 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

837 clinical trials

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Region Hovedstaden
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ALLOGENEIC VEIN TISSUE SEGMENT, DECELLULARISED, WITH A FUNCTIONAL VALVE PERFUSED WITH AUTOLOGOUS PERIPHERAL BLOOD
  • Sponsor:VeriGraft AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Quell Therapeutics Limited
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Gadoteric Acid
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate Ph. Eur.
  • Sponsor:Institute Of Oncology Ljubljana
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ANXV
  • Sponsor:Annexin Pharmaceuticals AB (publ)
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:[18F]DED
  • Sponsor:Barcelonabeta Brain Research Center
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Levosimendan
  • Sponsor:Tenax Therapeutics Inc.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Universitair Medisch Centrum Groningen
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:HUMAN IGG4 KAPPA MONOCLONAL ANTIBODY AGAINST PLATELET-DERIVED GROWTH FACTOR SUBUNIT B
  • Sponsor:Regeneron Pharmaceuticals Inc.

Substances studied in this area

The therapies tested most often in Vascular disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.